SMCHD1 is a target for gene activation therapy to treat Prader-Willi syndrome. (science.org)

Authors: Iminitoff M … Blewitt ME Journal: Science Advances Published: 2026-10-09 DOI: https://doi.org/10.1126/sciadv.aej5702